Biotech Smart Money

Biotech’s smart money is already focused on disease prevention, boosting immune systems and longevity
‘Health is the new wealth’ thanks to the coronavirus pandemic
The COVID-19 pandemic will change the global business landscape to its core. Investors are switching their attention from what was previously considered important — sectors such as real estate, tourism and hospitality — to what is truly important: human health.

The pandemic clearly will provide a tremendous boost to the biotech and bio-medicine industries, with a particular emphasis on preventive medicine. Recently, for example, two venture-funded rounds of more than $1 billion each (Arch Venture Partners and Qiming Venture Partners) were finalized. Meanwhile, several biotech companies closed sizeable funding rounds (e.g., Mabwell biotech’s recent $278.5 million Series A injection, iTeos Therapeutics’ recent $125 million Series B2 financing, Affinivax's recent $120 million Series B round, among others).
Accordingly, expect to see a dramatic rise in the volume of investments going to healthcare in general, and preventive medicine in particular, including diagnostic and prognostic technologies. Money will also be earmarked for the detection and neutralization of diseases in advance of their pathological progression. All of this funding has one major goal: to strengthen the performance of the human immune system.
Our frontier technology-focused consortium, Deep Knowledge Group, understands the scale and scope of the progressive healthcare and longevity industry, and of what “longevity” actually means in practice. Specifically, instead of focusing exclusively  on what can be considered as core geroscience (R&D-stage therapies focused on treating the hallmarks, or root causes, of biological aging), our framework includes other relevant sectors, ranging from the biomedical to the technological and financial. In our view, the longevity industry encompasses anything promoting a healthy life in all its forms: physical; psychological and financial.

From a biomedical perspective, one of the biggest factors is optimizing the performance of the human immune system. You cannot live long if you are not properly protected from pandemic threats. For example, supercentenarians — people who have lived at least 110 years — possess certain features fostering a strengthened immune system, thus neutralizing diseases early in their lives and enabling greater protection from microbes, bacteria and viruses.


To advance such understanding, we expect investors to prioritize the sub-sectors with the greatest potential for disruptive impact: digital health; biomarkers of longevity, and in particular, artificial intelligence for healthcare, drug discovery, preventive medicine, and longevity, which is a major priority for our longevity-focused investment fund, Longevity.Capital.

Enhanced immunity is one of the most fundamental ways to improve health outcomes in the elderly, the group most at risk for infection, pathology and death during pandemics. Anti-pandemic (immune system optimizing) strategies and approaches for maximizing healthy longevity go hand-in-hand — another reason why the current pandemic will lead to a rise in longevity-focused investment.

Health is the new wealth
COVID-19 will reshape biotech, preventive medicine, precision health and longevity efforts in substantial and largely positive ways. One of the secondary goals behind the creation of Deep Knowledge Group’s new COVID-19 MedTech Analytics IT-Platform was exactly this — obtaining a deeper and more tangible understanding of how trends in biotech investment and industry development generally will change and adapt in the wake of the current COVID pandemic.

This platform is designed to serve as a comprehensive database of the most relevant entities, technologies, and developments in the COVID-19 MedTech ecosystem — aggregating, profiling and visualizing the companies, organizations, scientists and technologies at the forefront of neutralizing the COVID-19 pandemic and ensuring the health and safety of individuals and nations. The platform aims to cover all major sectors and relevant activities in the global COVID-19 MedTech landscape, from science to technology, R&D, treatment, diagnostic and vaccine development, and practical applications occurring globally, providing data on particular scientific and technological sectors and geographical regions.

The COVID-19 pandemic will bring significant investments and developments to the biotech and bio-medicine industries, as well as a shift from treatment and healthcare (which can in practice be viewed as “sick care”) towards early-stage prevention, diagnosis, and tangible, data science-driven enhancement of the immune system and extension of the healthy period of life. This trend in turn will lead to an increase in global financial growth and stability by reducing the economic burden of age-related diseases, and by neutralizing the significant risks an aging population poses to the health, stability and vitality of national economies.

Our previous assessment of the longevity industry’s growth predicted a market value of $27 trillion by 2026. Yet considering the impact that COVID-19 is making on biotech investments, we see this figure as being much larger. COVID-19 will grow the rate and size of biotech investments generally, and investments in preventive medicine, precision health and healthy longevity in particular.

Health is the new wealth. The pandemic is causing many people to realize what is truly important in life, and to view their personal health and longevity as the most valuable asset class of all.

The Economy: U.S and World Economic News

 Get breaking economic news and analysis on the U.S. and global economy 

People also ask

Will there be a recession in 2020?

What will happen to the economy in 2020?

What is the current state of the US economy 2020?

What are the 10 largest economies in the world?

Read about thriving and emerging markets, the global economy, and the latest financial data and forecasts.

Finance Economics

 Even in a bad economy people still need to borrow money from credit card companies. Investors can bet against the revolving credit of consumers to get started you can look for mutual funds and exchange traded funds known as ETFs.


Financial service companies can be lumped together so to see the biggest gains of profits it is recommended to invest in individual stocks such as American Express, Discover Card, MasterCard, and Visa.

International Market Growth

One of the major reasons for looking at diversification is that the emerging market growth of credit volume outside of the U.S. has investors taking another look at consumer credit share repurchase programs which give earnings to those who have direct stocks or ETFs in their portfolios.

When it comes to equities associated with finance the residual claim or interest after all liabilities are paid it is important for investors to know the difference between if the liability exceeds assets or if  negative equity exists.

For example in the case of a stockholders equity, shareholders funds, or capital the remaining interest in assets of a company will be spread among individual shareholders of common or preferred stock.

Low vs High Risk

The interesting thing about finance and economic is that you are putting your money into a instrument that is expected to gain a profit from careful analysis of the market.

That is why most beginners want the security of knowing the degree of principle is high enough after a specified period of time. The difference with investing in oil and gas exploration is that there is no surety of (ROI) return on investment so it leads to much speculation. 

Low risk would be what is known as a fixed income because your receiving payments on a schedule which is what you get from pensions and government bonds.

Credit card debt is unsecured and accumulates with interest and penalties when this happens the consumer may end up paying higher interest rates because of defaulting on the amount of money borrowed. 

ETNs and ETFs

The exchange traded note is dependent on the credit rating known as debt securities, so the return you receive is based on the performance of the market. Funds traded on the stock exchange will hold assets such as stocks, commodities, and bonds that have an asset value. 

Average working people can get started due to the low cost and tax efficiency. Formally index funds are now actively managed from the authorization of the U.S. Securities and Exchange Commission. 

Source: Investing in Credit - Boomberg Businessweek

Disclaimer: This is for informational purposes only and is not meant to give investment advice, it is recommended that you consult an investment broker before putting your money into any stocks.

Dick's Sporting Goods Cracker Barrel Wayfair

Susquehanna Financial Group forecasts that Dick's Sporting Goods Inc. DKS, -1.57% will be the last national athletic retailer in business after the coronavirus pandemic thanks to factors including its balance sheet and digital capabilities. Other athletic retailers include Hibbett Sports Inc. HIBB, 2.51% and Foot Locker Inc. FL, 5.73%. "Dick's is reaping the benefits from heavy investment in its omnichannel capabilities over the past several years, enabling the company to be extremely flexible and nimble in the way it serves customers," analysts led by Sam Poser wrote. "This flexibility has been evident during the crisis, when selling through the brick-and-mortar channel has not been an option." Dick's Sporting Goods was able to transition to curbside pickup with ease thanks to these investments, analysts say. And they highlight a 250% jump in e-commerce sales in the second quarter thus far. Analysts say there could be some "fleeting" pent-up demand due to the coronavirus pandemic, but also say Dick's Sporting Goods has a "structural advantage" that will help it versus the competition in the long run. Susquehanna rates the stock positive with a $48 price target, up from $31. Data from retail intelligence company Placer.ai shows that in some states including Arizona and South Carolina traffic returned to year-over-year growth by May 20. Dick's Sporting Goods reported wider-than-expected losses on Tuesday. The stock is down 1.3% in Wednesday trading, and has slumped 24.7% for the year to date. The S&P 500 index SPX, 1.07% is down 3.6% for 2020 so far.

Shares of Cracker Barrel Old Country Store Inc. CBRL, +9.74% soared 11.4% in Wednesday trading after the restaurant and retail chain was upgraded to buy from hold at SunTrust Robinson Humphrey. Analysts moved their price target to $133 from $117. SunTrust cites near-term dine-in same-restaurant sales, which are down 32% for the week ending May 29, with the company expected to offer dine-in service systemwide on June 30. Analysts also think Cracker Barrel's "rural exposure and everyday value [mitigates] COVID and economic risks." Cracker Barrel announced fiscal third-quarter earnings on Tuesday. The company posted a net loss of $161.9 million, or $6.81, after earnings of $50.4 million, or $2.09, last year. Adjusted loss per share was $1.81. Revenue totaled $432.5 million, down from $739.6 million last year. The FactSet consensus was for losses of $1.06 per share and revenue of $477.8 million. Same-restaurant sales were down 41.7% for the quarter, and same-store sales were down 45.5%. Cracker Barrel stock has slumped 22.5% for the year to date while the S&P 500 index SPX, +1.06% is down 3.7%.

Wayfair stock is trading sharply higher Tuesday, getting a lift from bullish comments from Piper Sandler retail analyst Peter Keith, who says tailwinds the online home-furnishings retailer saw in April largely continued in May.


Wayfair’s (ticker: W) strong first-quarter results, reported on May 5, triggered a surge in the company’s shares that has not really stopped. Revenue in the quarter rose 19.8%, which was a bit ahead of estimates, but the stunner was the company’s disclosure that second-quarter revenue at that point...



Wayfair Stock Has Rocketed 700% Since March. Why There May Be More Gains Ahead.


Biotech, Preventive Medicine, Health and Longevity

Biotech’s smart money is already focused on disease prevention, boosting immune systems and longevity
‘Health is the new wealth’ thanks to the coronavirus pandemic
The COVID-19 pandemic will change the global business landscape to its core. Investors are switching their attention from what was previously considered important — sectors such as real estate, tourism and hospitality — to what is truly important: human health.

The pandemic clearly will provide a tremendous boost to the biotech and bio-medicine industries, with a particular emphasis on preventive medicine. Recently, for example, two venture-funded rounds of more than $1 billion each (Arch Venture Partners and Qiming Venture Partners) were finalized. Meanwhile, several biotech companies closed sizeable funding rounds (e.g., Mabwell biotech’s recent $278.5 million Series A injection, iTeos Therapeutics’ recent $125 million Series B2 financing, Affinivax's recent $120 million Series B round, among others).
Accordingly, expect to see a dramatic rise in the volume of investments going to healthcare in general, and preventive medicine in particular, including diagnostic and prognostic technologies. Money will also be earmarked for the detection and neutralization of diseases in advance of their pathological progression. All of this funding has one major goal: to strengthen the performance of the human immune system.
Our frontier technology-focused consortium, Deep Knowledge Group, understands the scale and scope of the progressive healthcare and longevity industry, and of what “longevity” actually means in practice. Specifically, instead of focusing exclusively  on what can be considered as core geroscience (R&D-stage therapies focused on treating the hallmarks, or root causes, of biological aging), our framework includes other relevant sectors, ranging from the biomedical to the technological and financial. In our view, the longevity industry encompasses anything promoting a healthy life in all its forms: physical; psychological and financial.

From a biomedical perspective, one of the biggest factors is optimizing the performance of the human immune system. You cannot live long if you are not properly protected from pandemic threats. For example, supercentenarians — people who have lived at least 110 years — possess certain features fostering a strengthened immune system, thus neutralizing diseases early in their lives and enabling greater protection from microbes, bacteria and viruses.


To advance such understanding, we expect investors to prioritize the sub-sectors with the greatest potential for disruptive impact: digital health; biomarkers of longevity, and in particular, artificial intelligence for healthcare, drug discovery, preventive medicine, and longevity, which is a major priority for our longevity-focused investment fund, Longevity.Capital.

Enhanced immunity is one of the most fundamental ways to improve health outcomes in the elderly, the group most at risk for infection, pathology and death during pandemics. Anti-pandemic (immune system optimizing) strategies and approaches for maximizing healthy longevity go hand-in-hand — another reason why the current pandemic will lead to a rise in longevity-focused investment.

Health is the new wealth
COVID-19 will reshape biotech, preventive medicine, precision health and longevity efforts in substantial and largely positive ways. One of the secondary goals behind the creation of Deep Knowledge Group’s new COVID-19 MedTech Analytics IT-Platform was exactly this — obtaining a deeper and more tangible understanding of how trends in biotech investment and industry development generally will change and adapt in the wake of the current COVID pandemic.

This platform is designed to serve as a comprehensive database of the most relevant entities, technologies, and developments in the COVID-19 MedTech ecosystem — aggregating, profiling and visualizing the companies, organizations, scientists and technologies at the forefront of neutralizing the COVID-19 pandemic and ensuring the health and safety of individuals and nations. The platform aims to cover all major sectors and relevant activities in the global COVID-19 MedTech landscape, from science to technology, R&D, treatment, diagnostic and vaccine development, and practical applications occurring globally, providing data on particular scientific and technological sectors and geographical regions.

The COVID-19 pandemic will bring significant investments and developments to the biotech and bio-medicine industries, as well as a shift from treatment and healthcare (which can in practice be viewed as “sick care”) towards early-stage prevention, diagnosis, and tangible, data science-driven enhancement of the immune system and extension of the healthy period of life. This trend in turn will lead to an increase in global financial growth and stability by reducing the economic burden of age-related diseases, and by neutralizing the significant risks an aging population poses to the health, stability and vitality of national economies.

Our previous assessment of the longevity industry’s growth predicted a market value of $27 trillion by 2026. Yet considering the impact that COVID-19 is making on biotech investments, we see this figure as being much larger. COVID-19 will grow the rate and size of biotech investments generally, and investments in preventive medicine, precision health and healthy longevity in particular.

Health is the new wealth. The pandemic is causing many people to realize what is truly important in life, and to view their personal health and longevity as the most valuable asset class of all.

Private Companies Go Public

After a few months of slim pickings, the U.S. initial public offering market is expected to reopen with a bang this week with the biggest deal of the year expected to price later Tuesday.
Warner Music Group Corp. is returning to public markets after nine years of being private and is expected to raise up to $1.82 billion by selling 70 million shares priced at $23 to $26 each.
“It’s going to be the busiest week in quite a while,” said Kathleen Smith, principal at Renaissance Capital, a provider of institutional research and IPO-related exchange- traded funds.
Warner Music, one of three large companies that dominate the recorded-music industry, is the parent company for prominent record labels including Atlantic Records, Warner Records and Elektra Records, and mentions artists Ed Sheeran, Bruno Mars, Cardi B, Twenty One Pilots, Lizzo and Katy Perry in its filing.
In its most recently completed fiscal year ended Sept. 30, 2019, it had profit of $258 million on revenue of $4.48 billion. In the two previous fiscal years, Warner Music had net income of $312 million and $149 million, and revenue of $4.01 billion and $3.58 billion, according to the filing.
After going public in 2005, Warner Music was taken private by Access Industries Inc. in 2011 for $3.3 billion. Rival Universal Music Group was valued at roughly $34 billion last year in investments from around the globe. Access will still have control of the company, once the deal is complete.
Morgan Stanley, Credit Suisse and Goldman Sachs are lead underwriters with BofA Securities, Citgroup and JP Morgan acting as joint bookrunners. Another 23 banks are acting as co-managers. The company has applied to list on Nasdaq, under the ticker symbol “WMG.”
The IPO market has had a dry period during the coronavirus pandemic, with only a few small biotechs and blank-check companies, or special purpose acquisition companies (SPACs) venturing forth, according to Smith from Renaissance Capital. Blank-check companies have no set business until they acquire one with the money raised in an IPO.
While the secondary market has been on fire—May’s dollar volume of share offerings is the biggest since 2014, according to BTIG, as companies moved to bolster liquidity positions—new issuers have had to wait for an equity market recovery from its pandemic lows, that has now arrived.
Proceeds from IPOs are down 64% in the year to date, compared with the same period a year ago. The number of deals that have been completed is down 42% from a year ago, excluding SPACs, she said.
But the Renaissance IPO ETF has set fresh records in recent weeks, thanks to the inclusion in the fund of recently public digital companies and others that are benefiting from working-from-home products and services, such as Zoom Video Communications Inc. ZM, 0.55%, Slack Technologies Inc. WORK, 2.77% and biotech Moderna Inc. MRNA, -4.93% which is developing a COVID-19 vaccine, she said.
The ETF has gained 26% in the past month and is up 21% on the year, easily outperforming the S&P 500’s SPX, 0.33% one-month gain of 8.4% and year-to-date decline of 5%.
“The performance of the IPO ETF IPO, 0.72% is what fans the flames and drives issuance,” she said. “And the deals that have priced are trading well, which gives investors the confidence to look at new issues.”
Warner Music and other private companies that come to market soon “will get the red carpet treatment,” she said.
In a further sign of improved market sentiment, ZoomInfo Technologies Inc. ZI, , a platform that generates sales leads for businesses, raised the expected price range for its planned deal early Tuesday to $19 to $20 a share from a previous $16 to $18. The company is planning to sell 44.5 million shares to raise $890 million at the top of that range.
J.P. Morgan and Morgan Stanley are underwriting the deal. For the three months ended March 31, the company recorded a loss of $5.9 million, narrower than the loss of $40.2 million posted in the year-earlier period. Revenue roughly doubled to $102.2 million, from $54.6 million.
Two other pending deals will offer clues as to investor appetite for new paper; Chinese gaming company NetEase Inc. NTES, 2.56%, which is planning a secondary listing for its stock on the Hong Kong stock exchange on June 11, and online use-car seller Vroom Inc. VRM, , which is hoping to capture part of the market that rival Carvana Co. CVNA, 17.74% has enjoyed since it went public in 2017.
“NetEase will be a test of whether Chinese IPOs can get done, and Vroom will test appetite for money-losing but fast-growing companies,” said Smith.
NetEase’s move is seen as defensive as the U.S. cracks down on Chinese listings and seeks greater disclosures from issuers.
Vroom reported a first-quarter net loss of $27.1 million, narrowing from $41.1 million in the year-ago period. Vroom’s revenue rose to $375.8 million from $235.1 million a year ago. Vroom’s revenue is primarily from its retail vehicle sales, which accounted for $308.7 million in the first quarter.
After that, Smith is expecting a burst of activity in the summer, when the many venture-capital and private-equity backed companies currently on the sidelines come to market to raise much-needed capital.
The November presidential election is expected to prompt another pause in activity, if 2020 behaves like a typical election year, she said.

MoneyGram and Western Union Merge


Shares of MoneyGram International Inc. MGI, 27.03% soared in after-hours trading Monday after a report that Western Union Co. WU, 11.18% was looking to acquire it. Bloomberg News reported the potential takeover, which was said to be still under discussion. No purchase price was reported. A deal would combine two of the biggest money-transfer services in the U.S. MoneyGram shares ended the extended session up 32%, at $3.41 a share, after peaking as high as 74%. The company has a market cap of $176.5 million as of the end of trading Monday. MoneyGram stock has risen 23% year to date, and 86% over the past 12 months. Western Union shares rose more than 6% after hours, but are down 23% in 2020.
_______________________________________________

Microsoft Could Be a $2 Trillion Company. Analyst Sees Gains From Cloud Business.

Microsoft stock has climbed more than 15% in 2020 as the company has avoided much impact from Covid-19. Yet Wells Fargo argues that the shares have more room to run—and that the tech giant’s market capitalization could grow to more than $2 trillion on the strength of its Azure cloud-computing business.

Analyst Philip Winslow reiterated an Outperform rating on Microsoft Tuesday, while boosting his target for the stock price to $250 from $205, based on the strength of the company’s cloud offerings.

Apple Is the World’s Most Highly Valued Company. Why It Could Soar Much Higher.

Apple is the world’s most highly valued company, with a market capitalization of $1.389 trillion. With the stock nearing the record closing level of $327.20 it hit in February, it is reasonable to wonder how much further it can go.

Evercore ISI analyst Amit Daryanani thinks the stock can go higher, and maybe a lot higher.


The growth of goods and services

Some speculate that the debt ceiling agreement is just one step towards the decline of the U.S. Dollar leading to the price levels within the economy to increase rapidly while currency loses its value.

Is Washington really trying to make a difference?An unchecked increase in the money supply experienced by the delayed spending cuts which will take place in 2020 is a recipe for disaster.

Instead it looks as if they are just trying to push the deficit problems on to the next person who is elected into office. The reason for this is that the price inflation is out of control and unregulated leaving the purchasing power of the dollar to sink.

Only time will tell and the true answer will come if any of the promises made are followed through. Things to consider is that interest rates will not continue to stay at a low rate, food prices will not stay affordable for most Americans, it just could be the default by inflation that is coming in the next decade.

As you are probably aware the main cause of hyperinflation is from the rapid increase in the amount of bank credit, or currency that is unable to keep up with the growth of goods and services.

Paper Money or Gold and Silver

It is this imbalance between the supply and demand for the paper money leading to a rise in prices causing inflation and people lose confidence in the economy.

Since gold can be used as a monetary exchange it is known as hard currency along with silver and other commodities. Many believe that putting money into bullion coins or gold bars will hedge against inflation or an economic depression.

Just printing more money is not the answer and increasing bank credit or printing currency will only make matters worst as has been seen when Bernanke's press conference disclosed the buying of treasury bonds to stimulate economic spending.

Is Inflation protection possible?

These attempts to stimulate the economy has proven to devalue or just delay a inevitable market crash. Investors turn to inflation protected securities. The real rate over return of inflation with no credit risks in asset classes with fixed income securities and equities being a popular choice.

Knowing what your inflation will be during the life of your bond is how you get a real rate of return with an IPS. The entire accrued principle is paid out at maturity giving you interest payments in two parts.

Source: Read more about Treasury Inflation Protected Securities and Bond articles at Investopedia.

Economic Recovery

Depending on which programs get cut employers will not be creating any more jobs and unemployment will continue to rise. Spending cuts over the next decade will effect the weaking economy.

What areas could see less money?

So far there has been mention of military cuts, but the biggest cuts will come down the line to federal programs which include highway construction, housing assistance and government sponsored research.

Defense departments will feel the squeeze as more economist discuss how cutting too deep will make it harder to see a economic recovery.

The federal deficit is estimated to be cut by trillions of dollars. It looks as another recession is ahead for Americans who are already feeling the loss of jobs and housing.

Will Treasury Bonds be a Safe Haven?

The long term interest rate of the 10- year treasury note has analyst anticipating a relief over the debt ceiling deal. Businesses spending more cash is unlikely considering the employment data showing a decline in new jobs being added.

Fiscal Spending Reductions

The global economy from Europe, China and Japan is showing a slowing down for fear of inflation. If we look at the breakdown of government spending in the U.S. we notice a pattern.

Programs that are effected the most are: Pensions, Healthcare, Education, National Defense, and Welfare. How much will be cut has not been determined.

What about Social Security, Medicare and Medicaid ?

It has been a long debate as to how much money is going to be available for future generations when it comes to Social Security benefits which is a insurance program funded through payroll taxes known as the Federal Insurance Contributions Act tax.

As for Medicare it is a U.S. program that provides health insurance coverage to people who are aged 65 and over. This also includes those who are under 65 and are disabled or have a physical disability.

Despite a unfavorable heathcare system Medicaid is a U.S. health program for low income adults, families and their children, as well as those with disabilities.

As long as the United States public debt is a measured by the obligations of the United States federal government and is presented by the United States Treasury the people will receive federal budget cuts in programs that matter most.

Millionaires Give Away Money

The stock exchange has a list of oil and gas companies in which you can invest in bonds and stock options. Risk is involved whether you buy commodity contracts, mutual funds or certificate of deposits.

You will have more available investment options with your self directed IRA. The reason is due to the tax free profits, tax deductions, asset protection and estate planning options.

If this is something you are interested in then you will want to check out fractional interest oil and gas leases with your 401K custodian.

IRA investment options for your retirement fund

The only way you will be able to take advantage of these asset growth stocks is to set up an account with a Self Directed Individual Retirement Account.

By selecting your own investments you can diversify your portfolio to include high and low risk assets such as precious metals, limited liability companies, mortgages and deeds of trust, partnerships and joint ventures.

It will only be from these alternatives from  your employee sponsored plan that you will be able to build your wealth after retirement.

How does a self directed IRA work?

The interesting thing about this type of  IRA is that it allows the account owner to make investment decisions and investments on behalf of the retirement plan.

As for the IRS regulations they require that a qualified trustee, or custodian hold the IRA assets on behalf of the IRA owner. This is so that they can maintain the assets and all transactions records.

You will be able to request your client statements and find out  the rules and regulations pertaining to your transactions,that you decide to invest in, such as stocks, bonds, and mutual funds.

Investing in oil and gas royalties

The benefits of a oil and gas income trust is that it focuses on the production and mining of a type of corporation in the U.S. or Canada whose profits are not taxed and are distributed to shareholders as dividends. This is how double taxation is avoided when the dividends are later taxed as personal income.

Royalty trusts will allow you to own the natural gas wells, or mineral rights of wells that is traded on the public stock market. The extraction of petroleum at mining properties gives you the power to hedge against inflation.

It is important to note that the high yields are based on interest rates, so to achieve high distribution returns investors can speculate on commodities without having to buy future contracts.

Things you should know about commodity based royalty trusts

Investing in natural resources and raw materials has its risks and can fall to the volatility of the commodity market. This is because the oil field in which your invested needs to be producing steady income based on the supply of oil.

The nature of oil field investments is that the oil eventually runs out and that is what makes investing in these types of assets different from other royalty trust such as iron ore assets. That is why you should be diversified into other assets such as renewable energy stocks which is an alternative to fossil fuels and nuclear energy.

source: Benefits of Royalty Trusts - nvestopedia.com/terms/r/royaltyincometrust.asp

Disclaimer: This is for informational purposes only and is not meant to give investment advice, it is recommended that you consult a investment broker before putting money into any type of stocks.

The Uranium Market

raditional sources of oil and coal are shifting to new alternatives. The future of clean energy is invested in solar, wind and biofuels, but another industry for those in support of nuclear energy is adding this emerging market to their portfolios to include uranium stocks.

Two of the power players for investors is with exchange traded funds such as Market Vectors Nuclear Energy. It is best to track uranium miners with The Global X Uranium ETF which will show all 25 whose holdings are primarily concentrated in Canada is performing well showing a return.

Hard rock mining requires several methods of extraction known as open pit mining which is done below the surface of sedimentary rock. Another process is called heap leaching where sulfuric acid is used to retrieve deposits from ore.

In-situ leaching is a solution mining technique that allows minerals to be discovered without disturbing the ore in the ground. The other nuclear power generation of fuel recovery is from seawater which is made possible by low concentration elements or inorganic absorbents known as titanium oxide compounds.

Scientist believe that the resource is limitless, the challenge will be keeping down the high cost of the various extraction methods being used, not to mention the fact that uranium ore emits radon gas making uranium mining dangerous compared to other underground mining. Leading to a need for adequate ventilation systems to be installed.

Why uranium is a good investment?

Plenty of people are excited about this precious metal because it is unlike any other basically for the fact that it is not traded on an organized commodity exchange such as the London Metal Exchange.

Mostly this makes it something that has to be negotiated directly between a buyer and a seller. When it comes to pricing it can vary from contract to contract so the buyer and seller agree on a base price that escalates over time on the basis of an specific formula. 

This is why you will see long term contracts ranging from two to 10 years. It is important to note that the uranium market commercial use for fueling nuclear reactors and generating electricity makes it a commodity market which can be volatile.

The processing can be a long one from mining it underground to fuel fabrication. Nuclear power plants will buy the uranium separately instead of from fuel bundles provided by fabricators, they do thisto get the best price and service.

Apparently sellers consist of suppliers in each of the four stages and includes brokers and traders with fewer than 100 companies to buy and sell uranium. Since the uranium markets are differentiated by geography you will see the global trading of uranium in two distinct marketplaces. 

The first being in Americas, Western Europe and Australia and the second in the former Soviet Union, or the Commonwealth of Independent States (CIS), Eastern Europe and China. 

Source: List of uranium mines en.wikipedia.org/wiki/List_of_uranium_mines

Disclaimer this is for informational purposes only and is not meant to give investment advice, it is recommended that you consult a investment broker before putting money into any type of stocks.

Currency Recession

If you are planning to invest in short term stocks the things that you must essentially remember to follow are reported stock charts and stock quotes. Currently, most stock charts and stock quotes are available online. So, all that you need to do is keep a vigilant watch on relevant stock charts to stay fully informed of the basic climate.

These stock charts are categorized on the basis of the duration of times that they cover. There are certain stock charts that provide an overview of the trade of a particular stock over the duration of a few days or weeks. On the other hand, there are certain stock charts, or stock quotes, that deliver an overview of the performance and trading statistics of a particular stock over a number of years.

Looking at these stock charts you will gain an idea of the history of the stock and you will also get a better impression on the performance of the stock. Most often, these charts can be stylized as line charts, bar charts, or candlestick charts. They can be demonstrated and displayed in a number of ways and depending on that, they are given various names. The most popular stock charts are the bar chart and candlestick charts, as they have the capability to show the high and the low prices for each day and week as well.

One of the benefits of following a stock chart is that it not only provides you with the details of the prices and their ranges, but also the date of those prices as well as the high, low, and closing prices. The moving average is also provided at the bottom of this chart. The moving average is the average price of the stock in the last few weeks. This will help you understand the stock quotes and the trends among them for a stipulated period of time. The patterns in the behavior should be understood and analyzed when you are reading stock charts. This is the primary use of stock charts.

One of the greatest benefits of following the stock quotes is that they provide short term stock traders with the certainty that is otherwise not liberally available. With the guidance of stock charts, you know when you should be investing in stocks. This will help you save your money to make the most of an investment. It is a good idea to keep a diligent eye on the way the stock chart behaves. Learn to analyze the chart, read the trends, and act in accordance with the movements. A regular analysis and idea of how the stock market performs and the way it fluctuates will help a person to gain confidence and a skilled sense of when to invest and how to deal with the investment.

Author :-
Ryan Harris is interested in the stock market, and he loves to get the latest info on stock charts. Get the latest info on stock quotes, feel free to visit the website.

Article Source:Author: Ryan Harris

Stock Profit Potential

Some of the most wealthiest people in the world are investors. They know how to find the right investments to earn them high dividends. With an estimated worth of several billion dollars, how do they find these undervalued growth stocks?

First it takes skill and an ability to read the markets. The better you become at seeing what others can't the richer you will become. You know the old saying "if everyone else is doing it than its time to get out"

The same holds true with purchasing stock options, if you remember the housing bubble it had many of the same characteristics that experienced investors call a herd mentality.

The people who made the most money in Real Estate were ones who could see an opportunity that the masses did not see. Once everyone and their brother started to buy properties this is when the veterans were selling and sitting on the money waiting for the frenzy to be over.

Once people started to lose interest in flipping houses and trying to earn money from rental properties. The heavy hitters came back in stronger than ever, buying up under-utilized land with a water source.

How to Find Low Priced Stock Picks with Profit Potential

There is a strategy that has been documented by individuals who have found success. You probably are familiar with Warren Buffet and how he made his fortune with Berkshire Hathaway.

He used some of these tactics to find winners. Students who study Buffets investment moves can learn a few tips in stock investing. He gives long term investment advice and his philosophy is considered old school but uses practical common sense.

Lets start by looking at some of Warren Buffett quotes: He says that it takes 20 years to build a reputation and only 5 minutes to ruin it so make your decisions wisely.

The rear-view mirror is always clearer than the windshield, so study history to know what the future has in store. If a business is doing well then the stock eventually will follow. Put your money in start-up companies that are innovative because they will have many more years ahead of them.

Buying winning stock picks requires a great deal of knowledge and homework. Look for companies that have good operating margins and low debt. If you are willing to wait it out and hold on to a stock until it reaches your target price then you will have what it takes to make lots of money from long term stock picks.

Disclaimer: This is for informational purposes only and is not meant to give any stock advice, it is recommended that you consult an investment broker before investing in any types of stocks.



Niche Ideas

Photo Editing Software
Video Editing Software
Certification Courses Online
Grammar Software
Rented Internal Organs
Social Psychology Experiment
Electromagnetic Pulses
Human Gnome DNA
Genetic Screening
Virtual Job Research Analyst
Memory Learning
Anti-Aging

2020 U.S. Economy Predictions

US Economic Outlook

What should you be looking at for the next decade?

Top 10 Small Business Trends Research News

1. Coconut Oil and Coconut Water

2.  Government Grants

3. American Dream Reinvented to Sustainable Living

4. Business Coaching Industry Grows

5. Corporations Hiring Freelancers

6. Outsourcing for Entrepreneurs

7. Small Business Globalization


How to Create Content that gets Clicks

I am excited to write about this topic simply because I have been experimenting with strategies to help boost visibility of my content online. One thing I have noticed is that when I am promoting my referral links on various websites the pages with attention-getting headlines seem to convert the best. I know these methods work because I am getting referrals to my business opportunities.

Creating content that gets clicks is an exact science and I am sure you are well aware of the power of words and how "what" you write in your ad campaigns can make a big difference.

Here are some of the things I have tried that work when trying to get more clicks on my links.

Copywriting sales letters can sometimes be very direct and to the point when it comes to the "call to action". As marketers we can learn a few things from those ads. Some of the things I use in my own articles is the term "Click Here" those two phrases really ramps up conversions. I think it is because people want to be given instructions as to what to do when they come to our pages and articles.

1. So the first tip is to make your call to action very clear to the reader.

2. Second tip is to create attention-getting headlines.

3. Write your press releases, articles and blog posts in a conversational tone

4. Share your story, when publishing content to promote your referrals make sure to give a review of the site or program your using.

5. Interlinking of blog and article content. I use about 5 different sites that I can use to interlink my content for increased web visits and clickthroughs.

The best tips I can give is to not try to sell but instead "encourage"

The most surprising thing about this strategy is that I am not selling anything, instead I am encouraging people to read my articles. For some reason people don't mind reading and then the sites I send future prospects to does the converting and closing.

I have other things that I am testing out in regards to getting more clicks on articles and when I finish getting results I will share them with you.

Have you found some tips on getting higher conversions on your content marketing? what is the best strategy so far that is working for you. Please share in the comments below:

Economic Solutions

The new energy economy has investors looking at oil shales which produce synthetic crude oil from the kerogen found in organic sedimentary rock.

Oil shale mining and processing can be found in Brazil, Germany, Israel and China. Environmentalist are concerned about the effect it will have on the air pollution as well as waste disposal and land use.

Shale oil extraction requires removing the material from above and underground. The chemical process of pyrolysis to convert the kerogen in the shale to oil is where the concerns of green house gas emissions comes from.

Because the processing and production costs are high many are determining if it will be economically feasible compared to the price of conventional oil. It looks as if the Bakken shale has more promise due to it being rich in natural gas.

Investors have the option of penny-stocks or ETF which are exchange traded funds on the stock exchange. As you search on the internet you will see a number of publicly traded oil and gas companies who are using drilling rigs in the Bakken region to discover more oil properties.

Some of the companies that are doing exploration and production for shale oil extraction are:

1. Concho Resources Inc. - they are an independent company providing acquisition, development and exploration of oil and natural gas properties in the Permian Basin of Southeast New Mexico and West Texas.

2. Abraxas Petroleum Corporation. - an independent energy company that provides acquisition, development, exploration, and production of oil and gas in the Rocky Mountain, Mid-Continent, Permian Basin, and  the province of Alberta, Canada.

3. EOG Resources Inc. - provides exploration, development, production, and marketing of natural gas, crude oil in U.S., Canada, the Republic of Trinidad, Tobago, United Kingdom, and China.

4. Continental Resources Inc.- independent oil and gas exploration and production company who searches for oil and natural gas assets beneath the North American continent, in the Rocky Mountain, Mid-Continent, and Gulf Coast regions.

5. Whiting Oil and Gas Inc. - provides the acquisition, exploitation, exploration, and production of oil and natural gas in the Gulf Coast/Permian Basin, Rocky Mountains, Michigan, the United States, and in Mountrail County, North Dakota.

6. Marathon Oil Corporation. - company explores for oil and gas in Angola, Canada, Equatorial Guinea, Libya, Norway, Indonesia, the UK, and the US.

Those who want to set up their investment portfolios can see the varying asset prices which can lead to major risks and potential of earning a profit. Other options are niche funds similar to the Stock Fund that will invest in the publicly traded companies along with those who drill in the Bakken Shale Formation.

Source: read more about the oil, gas and consumables fuel industry at Bloomberg Businessweek
Disclaimer: This is for informational purposes only and is not meant to give investment advice, it is recommended that you consult an investment broker before you put your money into any stocks.

World Health Organization News

The World Health Organization (WHO) is a specialized agency of the United Nations that is concerned with international public health. It was established on 7 April 1948, and is headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group. Its predecessor, the Health Organization, was an agency of the League of Nations.

The constitution of the WHO has been signed by 61 countries (all 51 member countries and 10 others) on 22 July 1946, with the first meeting of the World Health Assembly finishing on 24 July 1948. It incorporated the Office International d'Hygiène Publique and the League of Nations Health Organization.

Since its establishment, it has played a leading role in the eradication of smallpox. Its current priorities include communicable diseases, in particular Ebola, malaria and tuberculosis; the mitigation of the effects of non-communicable diseases such as reproductive health, development, and aging; nutrition, food security and healthy eating; occupational health; substance abuse; and driving the development of reporting, publications, and networking.

The WHO is responsible for the World Health Report, the worldwide World Health Survey, and World Health Day. The current Director-General of the WHO, Tedros Adhanom, also served as Ethiopian Health Minister from 2005 to 2012 and as Ethiopian Foreign Minister from 2012 to 2016. Adhanom started his five-year term on 1 July 2017

As of 2016, the WHO has 194 member states: all of the Member States of the United Nations except for the Cook Islands and Niue. (A state becomes a full member of WHO by ratifying the treaty known as the Constitution of the World Health Organization.) As of 2013, it also had two associate members, Puerto Rico and Tokelau. Several other countries have been granted observer status. Palestine is an observer as a "national liberation movement" recognized by the League of Arab States under United Nations Resolution 3118. The Holy See also attends as an observer, as does the Order of Malta. In 2010, Taiwan was invited under the name of "Republic of China".

WHO Member States appoint delegations to the World Health Assembly, WHO's supreme decision-making body. All UN Member States are eligible for WHO membership, and, according to the WHO website, "other countries may be admitted as members when their application has been approved by a simple majority vote of the World Health Assembly". Liechtenstein is currently the only UN member not in the WHO membership. The World Health Assembly is attended by delegations from all Member States, and determines the policies of the Organization.

The Executive Board is composed of members technically qualified in health, and gives effect to the decisions and policies of the Health Assembly. In addition, the UN observer organizations International Committee of the Red Cross and International Federation of Red Cross and Red Crescent Societies have entered into "official relations" with WHO and are invited as observers. In the World Health Assembly they are seated alongside the other NGOs

Top 10 Pharmaceutical Companies


If you were wondering about the ten largest pharmaceutical companies in the world then you will be interested in knowing how these big pharma companies account for more than a third of the industry's total market share according to the World Health Organisation.

I found this list and it is covering the current top ten companies along with their leading products and therapies.

10. Gilead Sciences - Revenue: $24.474 billion

The US biopharmaceutical company, best known for producing antivirals, also has a solid commercial portfolio of life-saving drugs in cardiovascular and respiratory therapies. Gilead secures its entry into the top ten list above several big pharma names because of incredible recent growth fueled by its brand new blockbuster hepatitis C drug, Sovaldi. Gilead's market leading medicines include treatments for HIV/AIDS, cancer, liver disease and cardiovascular disease.

9. Bayer - Revenue: $25.47 billion

The Leverkusen-based drug maker has an impressive commercial portfolio of more than 5000 products. In addition to human and veterinary pharmaceuticals, they also operate in consumer healthcare and agricultural chemicals. Bayer's top five drugs include anticoagulant Xarelto, eye medicine Eylea, cancer drugs Stivarga and Xofigo, and pulmonary arterial hypertension drug Adempas.

8. AstraZeneca - Revenue: $26.095 billion

AstraZeneca has a portfolio of products for major diseases, including cancer, cardiovascular disease, gastrointestinal infection, neurological disorders, respiratory disease and inflammation. Current top-selling products include cholestorol treatment Crestor, asthma therapy Symbicort and heartburn pill Nexium, and the UK-based pharmaceutical company is also said to have a strong pipeline of oncology therapies. AstraZeneca successfully fended off takeover bids from Pfizer in 2014 and has layed-out ambitious targets for future growth, which if successful could see it improve its rank among the top ten list of pharmaceutical companies.

7. GlaxoSmithKline - Revenue: $37.96 billion

GSK develops a broad range of products in pharmaceuticals, vaccines and consumer healthcare, and has leading products across various therapeutic areas including cardiovascular and respiratory disease, asthma, cancer, infections, mental health, diabetes and digestive conditions. GSK had good growth in emerging markets, Japan, and the company's HIV division last year, but its overall group turnover fell below their 2013 figures causing them to drop down the rankings. In April, Glaxo agreed more than $20 billion in deals with Novartis, selling its oncology business to and buying the bulk of Novartis' vaccine unit, making them the largest vaccines company globally. GSK applied for regulatory approval in 2014 for the first malaria vaccine and currently has one of the leading candidates for an Ebola vaccine undergoing clinical trials.

6. Merck - Revenue: $42.237 billion

Merck brought to market their highly promising cancer treatment Keytruda in 2014, one of six drugs that received FDA approval in the same year, including approvals for insomnia treatment Belsomra and Zerbaxa, the Cubist product approved to treat hospital-acquired infections. As of August 2014, Merck's research and development effort has led to the approval of more new drugs than any other company. Their specialist therapeutic areas include oncology, neurodegenerative diseases, fertility and endocrinology. Merck is also well known for publishing The Merck Manuals, a series of best-selling medical reference books for physicians, nurses and technicians.

5. Sanofi - Revenue: $43.07 billion

French pharmaceutical company Sanofi specialises in prescription and over the counter (OTC) medicines in seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. Diabetes blockbuster Lantus remains the source of much of the company's turnover, supported by vaccines and multiple sclerosis therapies at its biotech unit Genzyme, and antihistamine Allegra in Sanofi's consumer health division. At the beginning of February 2015, the Sanofi's R&D pipeline contained 43 projects (excluding Life Cycle Management) and vaccine candidates in clinical development of which 14 are in phase 3 or have been submitted to the regulatory authorities for approval.

4. Pfizer -Revenue: $49.605 billion

Pfizer develops and produces medicines and vaccines for a wide range of therapeutic areas including oncology, cardiology and immunology. Vaccine sales are comfortably keeping Pfizer among the world's biggest pharmaceutical companies, although generic medicines are now beginning to take their toll on some of their blockbusters, including Celebrex, Liptor and Viagra. However, Pfizer recently acquired leading sterile injectables company Hospira in a $17 billion (£11 billion) deal, which gives them access to a large portfolio of generics and biosimilar producs.

3. Roche - Revenue: $49.86 billion

Swiss pharmaceutical and biotechnology company Roche is well known for its innovative range of diagnostic solutions and medicines. Its best selling drugs include cancer treatments MebThera, Avastin, Herceptin and Xeloda. Roche is a front runner in personalised medicines and was one of the first companies to bring targeted treatments to patients.

2. Novartis - Revenue: $57.996 billion

Novartis heads the list of Switzerland's largest pharmaceutical companies and specialises in the development of biological therapies. The company, which consists of specialist divisions for prescription pharmaceuticals, eye care and generics and biosimilars, has a combined workforce of more than 100,000 employees, with operations in more than 140 countries worldwide. Its current top grossing pharmaceutical drugs include Gleevec for cancer and Gilenya for multiple sclerosis.

1. Johnson & Johnson - Revenue: $74.331 billion

Number one on the list of top pharmaceutical companies is no real surprise. Johnson & Johnson is a household name, largely thanks to its consumer healthcare division although it is a real powerhouse across a range of industries from medical devices to pharmaceutical and consumer goods. Johnson & Johnson has over 182 marketed drugs, with market leaders in hepititis C, arthritis, HIV/AIDS and digestive conditions.

Resource: http://blog.proclinical.com/who-are-the-top-10-pharmaceutical-companies-in-the-world

The great recession explained

The Great Recession was a period of general economic decline observed in world markets during the early 2000s. The scale and timing of the recession varied from country to country.In terms of overall impact, the International Monetary Fund concluded that it was the worst global recession since World War II. According to the US National Bureau of Economic Research (the official arbiter of US recessions) the recession, as experienced in that country, began in December 2007 and ended in June 2009, thus extending over 19 monthsThe Great Recession was related to the financial crisis of 2007–08 and U.S. subprime mortgage crisis of 2007–09. The Great Recession has resulted in the scarcity of valuable assets in the market economy and the collapse of the financial sector in the world economy.

Investing in Credit

Even in a bad economy people still need to borrow money from credit card companies. Investors can bet against the revolving credit of consumers to get started you can look for mutual funds and exchange traded funds known as ETFs.

Financial service companies can be lumped together so to see the biggest gains of profits it is recommended to invest in individual stocks such as American Express, Discover Card, MasterCard, and Visa.

International Market Growth

One of the major reasons for looking at diversification is that the emerging market growth of credit volume outside of the U.S. has investors taking another look at consumer credit share repurchase programs which give earnings to those who have direct stocks or ETFs in their portfolios.

When it comes to equities associated with finance the residual claim or interest after all liabilities are paid it is important for investors to know the difference between if the liability exceeds assets or if  negative equity exists.

For example in the case of a stockholders equity, shareholders funds, or capital the remaining interest in assets of a company will be spread among individual shareholders of common or preferred stock.

Low vs High Risk

The interesting thing about finance and economic is that you are putting your money into a instrument that is expected to gain a profit from careful analysis of the market.

That is why most beginners want the security of knowing the degree of principle is high enough after a specified period of time. The difference with investing in oil and gas exploration is that there is no surety of (ROI) return on investment so it leads to much speculation. 

Low risk would be what is known as a fixed income because your receiving payments on a schedule which is what you get from pensions and government bonds.

Credit card debt is unsecured and accumulates with interest and penalties when this happens the consumer may end up paying higher interest rates because of defaulting on the amount of money borrowed. 

ETNs and ETFs

The exchange traded note is dependent on the credit rating known as debt securities, so the return you receive is based on the performance of the market. Funds traded on the stock exchange will hold assets such as stocks, commodities, and bonds that have an asset value. 

Average working people can get started due to the low cost and tax efficiency. Formally index funds are now actively managed from the authorization of the U.S. Securities and Exchange Commission. 

Source: Investing in Credit - Boomberg Businessweek

Disclaimer: This is for informational purposes only and is not meant to give investment advice, it is recommended that you consult an investment broker before putting your money into any stocks.